BDNF and depressive symptom measurement: XYS can also regulate synapse- or synaptic-associated signaling pathways, including the neurotrophin signaling and PI3K/AKT signaling pathways, thereby alleviating depression (Meng et al., 2023; Yang S. et al., 2022).